Patents for A61P 27 - Drugs for disorders of the senses (53,017)
02/2007
02/15/2007WO2007017713A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof
02/15/2007WO2007016793A1 Galantamine as a neuroprotective drug for retinal ganglion cells
02/15/2007WO2005099715A9 Treatment of ophthalmic conditions with mineralcorticoids
02/15/2007US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
02/15/2007US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof
02/15/2007US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
02/15/2007US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
02/15/2007US20070037864 Intermediates for the preparation of lipoxin A4 analogs
02/15/2007US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells
02/15/2007US20070037834 Bicyclic pyrimidine derivatives
02/15/2007US20070037782 Therapeutic agent for ageing macular degeneration
02/15/2007US20070037606 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system
02/15/2007US20070036860 Treatment of allergic conditions
02/15/2007US20070036780 Modified proteins, designer toxins, and methods of making thereof
02/15/2007US20070036768 Systems and methods for treating patients with processed lipoaspirate cells
02/15/2007DE102005037499A1 Pyrazolderivate Pyrazole derivatives
02/15/2007CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators
02/15/2007CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents
02/15/2007CA2618360A1 Benzothiazoles and thiazolopyridines as sirtuin modulators
02/15/2007CA2618112A1 Pyridone compound
02/15/2007CA2617557A1 Benzimidazole derivatives as sirtuin modulators
02/15/2007CA2617532A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
02/15/2007CA2614857A1 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof
02/14/2007EP1752456A1 Corneal perception recovery drug containing amide compound
02/14/2007EP1752158A1 Corneal neuritogenesis promoter containing pacap and its derivative
02/14/2007EP1752152A1 Agent for visualizing transparent tissue
02/14/2007EP1751612A2 Methods and compositions for the treatment of uveitis
02/14/2007EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases
02/14/2007EP1750664A1 Intravitreal implants in conjunction with photodynamic therapy to improve vision
02/14/2007EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
02/14/2007EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/14/2007EP1395554B1 Substituted carbazoles as inhibitors of spla2
02/14/2007EP1392355B1 Use of proteasome inhibitors to treat dry eye disorders
02/14/2007EP1370552B1 Rho-kinase inhibitors
02/14/2007EP1343757B1 Indole derivatives
02/14/2007EP1341790B1 Sulfonamido ether substituted imidazoquinolines
02/14/2007EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
02/14/2007EP1280515B1 Pharmaceutical compositions comprising cannabis
02/14/2007EP1126836B1 Benzamide potassium channel inhibitors
02/14/2007EP1009413B1 Use of immunostimulatory oligonucleotides for preventing or treating asthma
02/14/2007CN1914211A Preventive or therapeutic agent for diabetic maculopathy
02/14/2007CN1913911A Physiologically functional drinks and compositions
02/14/2007CN1911915A Lactam compound and medicinal use thereof
02/14/2007CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism
02/14/2007CN1300173C Human antibodies that bind huma TNF 'alpha'
02/14/2007CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
02/14/2007CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
02/14/2007CN1299731C Hypometropia treating and asthenopia relieving Chinese traditional medicine and its preparation
02/14/2007CN1299710C Xiguashuang eye medicine and preparation process thereof
02/14/2007CN1299683C Celecoxib compositions
02/14/2007CN1299682C Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors
02/13/2007US7176219 Salts of quinuclidine derivative
02/13/2007US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors
02/13/2007US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases
02/13/2007US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity
02/13/2007US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved
02/13/2007US7175850 Formulation for topical non-invasive application in vivo
02/13/2007US7175849 Polypeptide for use in the treatment of viral disorders
02/08/2007WO2007015510A1 Method for prevention of degradation of thermally unstable substance
02/08/2007WO2007014462A1 Ep4 receptor agonist, compositions and methods thereof
02/08/2007WO2007014454A1 Ep4 receptor agonist, compositions and methods thereof
02/08/2007WO2006129318A3 Benzofuran derivatives with therapeutic activities
02/08/2007WO2006055526B1 Compositions useful to treat ocular neovascular diseases and macular degeneration
02/08/2007WO2006042252A3 Viral complement control proteins for eye disorders
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032538 Use of compounds
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032518 Compounds and methods of use
02/08/2007US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
02/08/2007US20070032466 Drug containing chymase inhibitor as the active ingredient
02/08/2007US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
02/08/2007DE112005000345T5 Verwendungen von Lycium barbarum Extrakten als neuroprotektive Mittel zur Behandlung der Degeneration von retinalen Ganglienzellen Lycium barbarum uses of extracts as neuroprotective agents for the treatment of degeneration of retinal ganglion cells
02/08/2007DE102005035986A1 Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat Sterile, droppable multiphase emulsifier-free ophthalmic preparation
02/08/2007CA2616608A1 Ep4 receptor agonist, compositions and methods thereof
02/08/2007CA2616604A1 Ep4 receptor agonist, compositions and methods thereof
02/07/2007EP1749541A1 Thickener for ophthalmic use
02/07/2007EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases
02/07/2007EP1748757A1 An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing
02/07/2007EP1506211B1 C-aryl glucoside sglt2 inhibitors and method
02/07/2007EP1315501B1 Alpha v integrin receptor antagonists
02/07/2007EP1231920B1 Use of epinastin for the treatment of allergic rhinitis/conjunctivitis
02/07/2007EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
02/07/2007EP1141308B1 Group b streptococcus proteins, and their use
02/07/2007EP1126875B1 Dispensing device for a pharmaceutically active composition
02/07/2007CN1910139A Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
02/07/2007CN1910138A L-(-)-moprolol l-(+)-tartrate
02/07/2007CN1909898A 滴眼剂组合物 The composition of eye drops
02/07/2007CN1907267A Chlorhydric acid pirenzepine solid preparation for eye-dripping and matching dissolvent thereof
02/07/2007CN1298862C Glycoprotein and process for producing same
02/07/2007CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions
02/07/2007CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof
02/07/2007CN1298704C Isatine derivatives with neurotrophic activity
02/07/2007CN1298385C Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof
02/07/2007CN1298344C Refreshing eyelid liniment for improving vision
02/07/2007CN1298343C Health eyeshade of combination of medication, preparation method and method of use
02/07/2007CN1298335C Chinese medicine for treating eye disease and preparing method thereof
02/07/2007CN1298333C Chinese medicine for treating epicophosis, sonitus
02/07/2007CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors